BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T093000
DTEND;TZID=America/Vancouver:20221006T120000
DTSTAMP:20260410T225502
CREATED:20220916T213841Z
LAST-MODIFIED:20220916T213841Z
UID:24089-1665048600-1665057600@scienceinvancouver.com
SUMMARY:From R&D to Commercialization: IP Essentials for Life Sciences Companies Presented by Gowling WLG
DESCRIPTION:We would like to invite you to join us for Life Sciences BC’s ‘From R&D to Commercialization: IP Essentials for Life Sciences Companies’ event presented by Gowling WLG \nOn October 6th\, Dr. Sonia Ziesche\, Principal and Patent Agent at Gowling WLG will join Wendy Hurlburt\, President and CEO at Life Sciences BC to discuss the IP journey of a life sciences company from research to commercialization. They will cover different types of IP protection\, patent requirements and obstacles\, IP best practices in the field of life sciences as well as tips on how to align IP strategy to advance business goals. \n\n\n\n\nSpeakers: \nDr. Sonia Ziesche\, Principal\, Patent Agent at Gowling WLG \nWendy Hurlburt\, President and CEO at Life Sciences BC \nTim Leaver\, Strategy and Danaher Business Systems Lead at Precision NanoSystems Inc. \n\n\n\n\nAgenda: \n4:30pm Registration \n5:00pm Panel Discussion and Q&As \n6:00pm Networking and Light Refreshments \n7:00pm Departure
URL:https://scienceinvancouver.com/event/from-rd-to-commercialization-ip-essentials-for-life-sciences-companies-presented-by-gowling-wlg/
LOCATION:Rosewood Georgia Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T093000
DTEND;TZID=America/Vancouver:20221006T120000
DTSTAMP:20260410T225502
CREATED:20220916T213841Z
LAST-MODIFIED:20220916T213841Z
UID:26595-1665048600-1665057600@scienceinvancouver.com
SUMMARY:From R&D to Commercialization: IP Essentials for Life Sciences Companies Presented by Gowling WLG
DESCRIPTION:We would like to invite you to join us for Life Sciences BC’s ‘From R&D to Commercialization: IP Essentials for Life Sciences Companies’ event presented by Gowling WLG \nOn October 6th\, Dr. Sonia Ziesche\, Principal and Patent Agent at Gowling WLG will join Wendy Hurlburt\, President and CEO at Life Sciences BC to discuss the IP journey of a life sciences company from research to commercialization. They will cover different types of IP protection\, patent requirements and obstacles\, IP best practices in the field of life sciences as well as tips on how to align IP strategy to advance business goals. \n\n\n\n\nSpeakers: \nDr. Sonia Ziesche\, Principal\, Patent Agent at Gowling WLG \nWendy Hurlburt\, President and CEO at Life Sciences BC \nTim Leaver\, Strategy and Danaher Business Systems Lead at Precision NanoSystems Inc. \n\n\n\n\nAgenda: \n4:30pm Registration \n5:00pm Panel Discussion and Q&As \n6:00pm Networking and Light Refreshments \n7:00pm Departure
URL:https://scienceinvancouver.com/event/from-rd-to-commercialization-ip-essentials-for-life-sciences-companies-presented-by-gowling-wlg-2/
LOCATION:Rosewood Georgia Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T093000
DTEND;TZID=America/Vancouver:20221006T120000
DTSTAMP:20260410T225502
CREATED:20220916T213841Z
LAST-MODIFIED:20220916T213841Z
UID:28210-1665048600-1665057600@scienceinvancouver.com
SUMMARY:From R&D to Commercialization: IP Essentials for Life Sciences Companies Presented by Gowling WLG
DESCRIPTION:We would like to invite you to join us for Life Sciences BC’s ‘From R&D to Commercialization: IP Essentials for Life Sciences Companies’ event presented by Gowling WLG \nOn October 6th\, Dr. Sonia Ziesche\, Principal and Patent Agent at Gowling WLG will join Wendy Hurlburt\, President and CEO at Life Sciences BC to discuss the IP journey of a life sciences company from research to commercialization. They will cover different types of IP protection\, patent requirements and obstacles\, IP best practices in the field of life sciences as well as tips on how to align IP strategy to advance business goals. \n\n\n\n\nSpeakers: \nDr. Sonia Ziesche\, Principal\, Patent Agent at Gowling WLG \nWendy Hurlburt\, President and CEO at Life Sciences BC \nTim Leaver\, Strategy and Danaher Business Systems Lead at Precision NanoSystems Inc. \n\n\n\n\nAgenda: \n4:30pm Registration \n5:00pm Panel Discussion and Q&As \n6:00pm Networking and Light Refreshments \n7:00pm Departure
URL:https://scienceinvancouver.com/event/from-rd-to-commercialization-ip-essentials-for-life-sciences-companies-presented-by-gowling-wlg-3/
LOCATION:Rosewood Georgia Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T093000
DTEND;TZID=America/Vancouver:20221006T120000
DTSTAMP:20260410T225502
CREATED:20220916T213841Z
LAST-MODIFIED:20220916T213841Z
UID:31293-1665048600-1665057600@scienceinvancouver.com
SUMMARY:From R&D to Commercialization: IP Essentials for Life Sciences Companies Presented by Gowling WLG
DESCRIPTION:We would like to invite you to join us for Life Sciences BC’s ‘From R&D to Commercialization: IP Essentials for Life Sciences Companies’ event presented by Gowling WLG \nOn October 6th\, Dr. Sonia Ziesche\, Principal and Patent Agent at Gowling WLG will join Wendy Hurlburt\, President and CEO at Life Sciences BC to discuss the IP journey of a life sciences company from research to commercialization. They will cover different types of IP protection\, patent requirements and obstacles\, IP best practices in the field of life sciences as well as tips on how to align IP strategy to advance business goals. \n\n\n\n\nSpeakers: \nDr. Sonia Ziesche\, Principal\, Patent Agent at Gowling WLG \nWendy Hurlburt\, President and CEO at Life Sciences BC \nTim Leaver\, Strategy and Danaher Business Systems Lead at Precision NanoSystems Inc. \n\n\n\n\nAgenda: \n4:30pm Registration \n5:00pm Panel Discussion and Q&As \n6:00pm Networking and Light Refreshments \n7:00pm Departure
URL:https://scienceinvancouver.com/event/from-rd-to-commercialization-ip-essentials-for-life-sciences-companies-presented-by-gowling-wlg-4/
LOCATION:Rosewood Georgia Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T093000
DTEND;TZID=America/Vancouver:20221006T120000
DTSTAMP:20260410T225502
CREATED:20220916T213841Z
LAST-MODIFIED:20220916T213841Z
UID:32753-1665048600-1665057600@scienceinvancouver.com
SUMMARY:From R&D to Commercialization: IP Essentials for Life Sciences Companies Presented by Gowling WLG
DESCRIPTION:We would like to invite you to join us for Life Sciences BC’s ‘From R&D to Commercialization: IP Essentials for Life Sciences Companies’ event presented by Gowling WLG \nOn October 6th\, Dr. Sonia Ziesche\, Principal and Patent Agent at Gowling WLG will join Wendy Hurlburt\, President and CEO at Life Sciences BC to discuss the IP journey of a life sciences company from research to commercialization. They will cover different types of IP protection\, patent requirements and obstacles\, IP best practices in the field of life sciences as well as tips on how to align IP strategy to advance business goals. \n\n\n\n\nSpeakers: \nDr. Sonia Ziesche\, Principal\, Patent Agent at Gowling WLG \nWendy Hurlburt\, President and CEO at Life Sciences BC \nTim Leaver\, Strategy and Danaher Business Systems Lead at Precision NanoSystems Inc. \n\n\n\n\nAgenda: \n4:30pm Registration \n5:00pm Panel Discussion and Q&As \n6:00pm Networking and Light Refreshments \n7:00pm Departure
URL:https://scienceinvancouver.com/event/from-rd-to-commercialization-ip-essentials-for-life-sciences-companies-presented-by-gowling-wlg-5/
LOCATION:Rosewood Georgia Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T180000
DTEND;TZID=America/Vancouver:20221006T210000
DTSTAMP:20260410T225502
CREATED:20220922T151702Z
LAST-MODIFIED:20220922T151702Z
UID:24157-1665079200-1665090000@scienceinvancouver.com
SUMMARY:UBC-BCIT Biotechnology Program Alumni Reunion
DESCRIPTION:The Joint UBC-BCIT Honors B.Sc. in Biotechnology Program\, a specialization of the Department of Microbiology and Immunology at UBC\, has been educating students for over 20 years. This reunion event is an opportunity to bring together current Biotechnology students\, alumni of the program\, faculty at both BCIT and UBC and program supporters in academia and industry. If you are an alumni or have been a supporter of this unique program over the last 20+ years\, come and reconnect\, expand your network and celebrate the success of the Biotechnology Program alumni in the local Life Sciences community and beyond. \nDetails: \nDate: Oct. 6th\, 2022\nTime: 6-9 PM\nLocation: Life Sciences Institute West Atrium\, UBC\nCost: Free for all students\, $15 for alumni and program supporters \nRefreshments and a cash bar will be available.
URL:https://scienceinvancouver.com/event/ubc-bcit-biotechnology-program-alumni-reunion/
LOCATION:Life Sciences Institute\, UBC\, 2350 Health Sciences Mall\, Vancouver
ORGANIZER;CN="BCIT Department of Biotechnology":MAILTO:sarah_mcleod@bcit.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T180000
DTEND;TZID=America/Vancouver:20221006T210000
DTSTAMP:20260410T225502
CREATED:20220922T151702Z
LAST-MODIFIED:20220922T151702Z
UID:26599-1665079200-1665090000@scienceinvancouver.com
SUMMARY:UBC-BCIT Biotechnology Program Alumni Reunion
DESCRIPTION:The Joint UBC-BCIT Honors B.Sc. in Biotechnology Program\, a specialization of the Department of Microbiology and Immunology at UBC\, has been educating students for over 20 years. This reunion event is an opportunity to bring together current Biotechnology students\, alumni of the program\, faculty at both BCIT and UBC and program supporters in academia and industry. If you are an alumni or have been a supporter of this unique program over the last 20+ years\, come and reconnect\, expand your network and celebrate the success of the Biotechnology Program alumni in the local Life Sciences community and beyond. \nDetails: \nDate: Oct. 6th\, 2022\nTime: 6-9 PM\nLocation: Life Sciences Institute West Atrium\, UBC\nCost: Free for all students\, $15 for alumni and program supporters \nRefreshments and a cash bar will be available.
URL:https://scienceinvancouver.com/event/ubc-bcit-biotechnology-program-alumni-reunion-2/
LOCATION:Life Sciences Institute\, UBC\, 2350 Health Sciences Mall\, Vancouver
ORGANIZER;CN="BCIT Department of Biotechnology":MAILTO:sarah_mcleod@bcit.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T180000
DTEND;TZID=America/Vancouver:20221006T210000
DTSTAMP:20260410T225502
CREATED:20220922T151702Z
LAST-MODIFIED:20220922T151702Z
UID:28214-1665079200-1665090000@scienceinvancouver.com
SUMMARY:UBC-BCIT Biotechnology Program Alumni Reunion
DESCRIPTION:The Joint UBC-BCIT Honors B.Sc. in Biotechnology Program\, a specialization of the Department of Microbiology and Immunology at UBC\, has been educating students for over 20 years. This reunion event is an opportunity to bring together current Biotechnology students\, alumni of the program\, faculty at both BCIT and UBC and program supporters in academia and industry. If you are an alumni or have been a supporter of this unique program over the last 20+ years\, come and reconnect\, expand your network and celebrate the success of the Biotechnology Program alumni in the local Life Sciences community and beyond. \nDetails: \nDate: Oct. 6th\, 2022\nTime: 6-9 PM\nLocation: Life Sciences Institute West Atrium\, UBC\nCost: Free for all students\, $15 for alumni and program supporters \nRefreshments and a cash bar will be available.
URL:https://scienceinvancouver.com/event/ubc-bcit-biotechnology-program-alumni-reunion-3/
LOCATION:Life Sciences Institute\, UBC\, 2350 Health Sciences Mall\, Vancouver
ORGANIZER;CN="BCIT Department of Biotechnology":MAILTO:sarah_mcleod@bcit.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T180000
DTEND;TZID=America/Vancouver:20221006T210000
DTSTAMP:20260410T225502
CREATED:20220922T151702Z
LAST-MODIFIED:20220922T151702Z
UID:31297-1665079200-1665090000@scienceinvancouver.com
SUMMARY:UBC-BCIT Biotechnology Program Alumni Reunion
DESCRIPTION:The Joint UBC-BCIT Honors B.Sc. in Biotechnology Program\, a specialization of the Department of Microbiology and Immunology at UBC\, has been educating students for over 20 years. This reunion event is an opportunity to bring together current Biotechnology students\, alumni of the program\, faculty at both BCIT and UBC and program supporters in academia and industry. If you are an alumni or have been a supporter of this unique program over the last 20+ years\, come and reconnect\, expand your network and celebrate the success of the Biotechnology Program alumni in the local Life Sciences community and beyond. \nDetails: \nDate: Oct. 6th\, 2022\nTime: 6-9 PM\nLocation: Life Sciences Institute West Atrium\, UBC\nCost: Free for all students\, $15 for alumni and program supporters \nRefreshments and a cash bar will be available.
URL:https://scienceinvancouver.com/event/ubc-bcit-biotechnology-program-alumni-reunion-4/
LOCATION:Life Sciences Institute\, UBC\, 2350 Health Sciences Mall\, Vancouver
ORGANIZER;CN="BCIT Department of Biotechnology":MAILTO:sarah_mcleod@bcit.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221006T180000
DTEND;TZID=America/Vancouver:20221006T210000
DTSTAMP:20260410T225502
CREATED:20220922T151702Z
LAST-MODIFIED:20220922T151702Z
UID:32757-1665079200-1665090000@scienceinvancouver.com
SUMMARY:UBC-BCIT Biotechnology Program Alumni Reunion
DESCRIPTION:The Joint UBC-BCIT Honors B.Sc. in Biotechnology Program\, a specialization of the Department of Microbiology and Immunology at UBC\, has been educating students for over 20 years. This reunion event is an opportunity to bring together current Biotechnology students\, alumni of the program\, faculty at both BCIT and UBC and program supporters in academia and industry. If you are an alumni or have been a supporter of this unique program over the last 20+ years\, come and reconnect\, expand your network and celebrate the success of the Biotechnology Program alumni in the local Life Sciences community and beyond. \nDetails: \nDate: Oct. 6th\, 2022\nTime: 6-9 PM\nLocation: Life Sciences Institute West Atrium\, UBC\nCost: Free for all students\, $15 for alumni and program supporters \nRefreshments and a cash bar will be available.
URL:https://scienceinvancouver.com/event/ubc-bcit-biotechnology-program-alumni-reunion-5/
LOCATION:Life Sciences Institute\, UBC\, 2350 Health Sciences Mall\, Vancouver
ORGANIZER;CN="BCIT Department of Biotechnology":MAILTO:sarah_mcleod@bcit.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221011T193000
DTEND;TZID=America/Vancouver:20221011T210000
DTSTAMP:20260410T225502
CREATED:20220908T161137Z
LAST-MODIFIED:20220926T201438Z
UID:23979-1665516600-1665522000@scienceinvancouver.com
SUMMARY:Science Slam YVR
DESCRIPTION:For those of you who have not yet experienced the wonder of Science Slam\, welcome! We are Vancouver’s most epic science showdown. Sit back\, relax\, and watch as our competitors battle to achieve science communication fame and glory. \nWhat exactly is a science slam? Based on the format of a poetry slam\, a science slam is a competition where speakers gather to share their science with you – the audience. Competitors have five minutes to present on any science topic without the use of a slideshow and are judged based on communication skills\, audience impact and scientific content. Props and creative presentation styles are encouraged! \nWhether you’re a researcher\, student\, educator\, artist\, or communicator\, our stage is open to you. If you’ve got a science topic you’re researching\, or just a topic you’re excited about\, send in an application! If you’re not sure about an idea\, just ask us at scislamca@gmail.com! \nApplication link: https://forms.gle/y5nQZwLzVUcRiHZT9 \nWe will be accepting applications until September 23\, 2022 and will be notifying our potential Slammers by September 30 to give enough time to prepare! \nAs this event is held in October\, feel free to be inspired by the Halloween season\, although this is certainly not necessary to apply. \nYouTube channel (for creative inspiration): https://www.youtube.com/channel/UCWmI8llf3pAW5xtbvnXmsog \nDoors open at 7pm\, event begins at 7:30pm. General admission $15\, first 50 tickets sold get the $12 early bird rate! \nSee you there! \nInterested in volunteering with Science Slam Canada? https://linktr.ee/scislamca \nNotes: \nThe venue is wheelchair accessible. The main cabaret room is accessible through a ramped entrance. We also have a wheelchair accessible washroom in the space as well. \nVenue is a 19+ venue with non-gendered bathrooms. \nMasks are not required but they are encouraged. \nCostumes are also not required\, but feel free to embrace the Halloween vibe by breaking out your costume early. \nScience Slam acknowledges that this event takes place on the traditional\, ancestral\, and unceded territory of the Squamish\, Sto:lo\, Musqueam\, and Tsleil Waututh Nation. Many of our attendees\, Science Slam included\, are guests of these territories and must act accordingly. \nScience Slam is an inclusive event\, as a result hate speech and abuse will not be tolerated.
URL:https://scienceinvancouver.com/event/science-slam-yvr-2/
LOCATION:Fox Cabaret\, 2321 Main Street\, Vancouver
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/fx1_lrg-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221011T193000
DTEND;TZID=America/Vancouver:20221011T210000
DTSTAMP:20260410T225502
CREATED:20220908T161137Z
LAST-MODIFIED:20220908T161137Z
UID:26594-1665516600-1665522000@scienceinvancouver.com
SUMMARY:Science Slam YVR
DESCRIPTION:For those of you who have not yet experienced the wonder of Science Slam\, welcome! We are Vancouver’s most epic science showdown. Sit back\, relax\, and watch as our competitors battle to achieve science communication fame and glory. \nWhat exactly is a science slam? Based on the format of a poetry slam\, a science slam is a competition where speakers gather to share their science with you – the audience. Competitors have five minutes to present on any science topic without the use of a slideshow and are judged based on communication skills\, audience impact and scientific content. Props and creative presentation styles are encouraged! \nWhether you’re a researcher\, student\, educator\, artist\, or communicator\, our stage is open to you. If you’ve got a science topic you’re researching\, or just a topic you’re excited about\, send in an application! If you’re not sure about an idea\, just ask us at scislamca@gmail.com! \nApplication link: https://forms.gle/y5nQZwLzVUcRiHZT9 \nWe will be accepting applications until September 23\, 2022 and will be notifying our potential Slammers by September 30 to give enough time to prepare! \nAs this event is held in October\, feel free to be inspired by the Halloween season\, although this is certainly not necessary to apply. \nYouTube channel (for creative inspiration): https://www.youtube.com/channel/UCWmI8llf3pAW5xtbvnXmsog \nDoors open at 7pm\, event begins at 7:30pm. General admission $15\, first 50 tickets sold get the $12 early bird rate! \nSee you there! \nInterested in volunteering with Science Slam Canada? https://linktr.ee/scislamca \nNotes: \nThe venue is wheelchair accessible. The main cabaret room is accessible through a ramped entrance. We also have a wheelchair accessible washroom in the space as well. \nVenue is a 19+ venue with non-gendered bathrooms. \nMasks are not required but they are encouraged. \nCostumes are also not required\, but feel free to embrace the Halloween vibe by breaking out your costume early. \nScience Slam acknowledges that this event takes place on the traditional\, ancestral\, and unceded territory of the Squamish\, Sto:lo\, Musqueam\, and Tsleil Waututh Nation. Many of our attendees\, Science Slam included\, are guests of these territories and must act accordingly. \nScience Slam is an inclusive event\, as a result hate speech and abuse will not be tolerated.
URL:https://scienceinvancouver.com/event/science-slam-yvr-2-2/
LOCATION:Fox Cabaret\, 2321 Main Street\, Vancouver
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/fx1_lrg-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221011T193000
DTEND;TZID=America/Vancouver:20221011T210000
DTSTAMP:20260410T225502
CREATED:20220908T161137Z
LAST-MODIFIED:20220908T161137Z
UID:28209-1665516600-1665522000@scienceinvancouver.com
SUMMARY:Science Slam YVR
DESCRIPTION:For those of you who have not yet experienced the wonder of Science Slam\, welcome! We are Vancouver’s most epic science showdown. Sit back\, relax\, and watch as our competitors battle to achieve science communication fame and glory. \nWhat exactly is a science slam? Based on the format of a poetry slam\, a science slam is a competition where speakers gather to share their science with you – the audience. Competitors have five minutes to present on any science topic without the use of a slideshow and are judged based on communication skills\, audience impact and scientific content. Props and creative presentation styles are encouraged! \nWhether you’re a researcher\, student\, educator\, artist\, or communicator\, our stage is open to you. If you’ve got a science topic you’re researching\, or just a topic you’re excited about\, send in an application! If you’re not sure about an idea\, just ask us at scislamca@gmail.com! \nApplication link: https://forms.gle/y5nQZwLzVUcRiHZT9 \nWe will be accepting applications until September 23\, 2022 and will be notifying our potential Slammers by September 30 to give enough time to prepare! \nAs this event is held in October\, feel free to be inspired by the Halloween season\, although this is certainly not necessary to apply. \nYouTube channel (for creative inspiration): https://www.youtube.com/channel/UCWmI8llf3pAW5xtbvnXmsog \nDoors open at 7pm\, event begins at 7:30pm. General admission $15\, first 50 tickets sold get the $12 early bird rate! \nSee you there! \nInterested in volunteering with Science Slam Canada? https://linktr.ee/scislamca \nNotes: \nThe venue is wheelchair accessible. The main cabaret room is accessible through a ramped entrance. We also have a wheelchair accessible washroom in the space as well. \nVenue is a 19+ venue with non-gendered bathrooms. \nMasks are not required but they are encouraged. \nCostumes are also not required\, but feel free to embrace the Halloween vibe by breaking out your costume early. \nScience Slam acknowledges that this event takes place on the traditional\, ancestral\, and unceded territory of the Squamish\, Sto:lo\, Musqueam\, and Tsleil Waututh Nation. Many of our attendees\, Science Slam included\, are guests of these territories and must act accordingly. \nScience Slam is an inclusive event\, as a result hate speech and abuse will not be tolerated.
URL:https://scienceinvancouver.com/event/science-slam-yvr-2-3/
LOCATION:Fox Cabaret\, 2321 Main Street\, Vancouver
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/fx1_lrg-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221011T193000
DTEND;TZID=America/Vancouver:20221011T210000
DTSTAMP:20260410T225502
CREATED:20220908T161137Z
LAST-MODIFIED:20220908T161137Z
UID:31292-1665516600-1665522000@scienceinvancouver.com
SUMMARY:Science Slam YVR
DESCRIPTION:For those of you who have not yet experienced the wonder of Science Slam\, welcome! We are Vancouver’s most epic science showdown. Sit back\, relax\, and watch as our competitors battle to achieve science communication fame and glory. \nWhat exactly is a science slam? Based on the format of a poetry slam\, a science slam is a competition where speakers gather to share their science with you – the audience. Competitors have five minutes to present on any science topic without the use of a slideshow and are judged based on communication skills\, audience impact and scientific content. Props and creative presentation styles are encouraged! \nWhether you’re a researcher\, student\, educator\, artist\, or communicator\, our stage is open to you. If you’ve got a science topic you’re researching\, or just a topic you’re excited about\, send in an application! If you’re not sure about an idea\, just ask us at scislamca@gmail.com! \nApplication link: https://forms.gle/y5nQZwLzVUcRiHZT9 \nWe will be accepting applications until September 23\, 2022 and will be notifying our potential Slammers by September 30 to give enough time to prepare! \nAs this event is held in October\, feel free to be inspired by the Halloween season\, although this is certainly not necessary to apply. \nYouTube channel (for creative inspiration): https://www.youtube.com/channel/UCWmI8llf3pAW5xtbvnXmsog \nDoors open at 7pm\, event begins at 7:30pm. General admission $15\, first 50 tickets sold get the $12 early bird rate! \nSee you there! \nInterested in volunteering with Science Slam Canada? https://linktr.ee/scislamca \nNotes: \nThe venue is wheelchair accessible. The main cabaret room is accessible through a ramped entrance. We also have a wheelchair accessible washroom in the space as well. \nVenue is a 19+ venue with non-gendered bathrooms. \nMasks are not required but they are encouraged. \nCostumes are also not required\, but feel free to embrace the Halloween vibe by breaking out your costume early. \nScience Slam acknowledges that this event takes place on the traditional\, ancestral\, and unceded territory of the Squamish\, Sto:lo\, Musqueam\, and Tsleil Waututh Nation. Many of our attendees\, Science Slam included\, are guests of these territories and must act accordingly. \nScience Slam is an inclusive event\, as a result hate speech and abuse will not be tolerated.
URL:https://scienceinvancouver.com/event/science-slam-yvr-2-4/
LOCATION:Fox Cabaret\, 2321 Main Street\, Vancouver
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/fx1_lrg-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221011T193000
DTEND;TZID=America/Vancouver:20221011T210000
DTSTAMP:20260410T225502
CREATED:20220908T161137Z
LAST-MODIFIED:20220908T161137Z
UID:32752-1665516600-1665522000@scienceinvancouver.com
SUMMARY:Science Slam YVR
DESCRIPTION:For those of you who have not yet experienced the wonder of Science Slam\, welcome! We are Vancouver’s most epic science showdown. Sit back\, relax\, and watch as our competitors battle to achieve science communication fame and glory. \nWhat exactly is a science slam? Based on the format of a poetry slam\, a science slam is a competition where speakers gather to share their science with you – the audience. Competitors have five minutes to present on any science topic without the use of a slideshow and are judged based on communication skills\, audience impact and scientific content. Props and creative presentation styles are encouraged! \nWhether you’re a researcher\, student\, educator\, artist\, or communicator\, our stage is open to you. If you’ve got a science topic you’re researching\, or just a topic you’re excited about\, send in an application! If you’re not sure about an idea\, just ask us at scislamca@gmail.com! \nApplication link: https://forms.gle/y5nQZwLzVUcRiHZT9 \nWe will be accepting applications until September 23\, 2022 and will be notifying our potential Slammers by September 30 to give enough time to prepare! \nAs this event is held in October\, feel free to be inspired by the Halloween season\, although this is certainly not necessary to apply. \nYouTube channel (for creative inspiration): https://www.youtube.com/channel/UCWmI8llf3pAW5xtbvnXmsog \nDoors open at 7pm\, event begins at 7:30pm. General admission $15\, first 50 tickets sold get the $12 early bird rate! \nSee you there! \nInterested in volunteering with Science Slam Canada? https://linktr.ee/scislamca \nNotes: \nThe venue is wheelchair accessible. The main cabaret room is accessible through a ramped entrance. We also have a wheelchair accessible washroom in the space as well. \nVenue is a 19+ venue with non-gendered bathrooms. \nMasks are not required but they are encouraged. \nCostumes are also not required\, but feel free to embrace the Halloween vibe by breaking out your costume early. \nScience Slam acknowledges that this event takes place on the traditional\, ancestral\, and unceded territory of the Squamish\, Sto:lo\, Musqueam\, and Tsleil Waututh Nation. Many of our attendees\, Science Slam included\, are guests of these territories and must act accordingly. \nScience Slam is an inclusive event\, as a result hate speech and abuse will not be tolerated.
URL:https://scienceinvancouver.com/event/science-slam-yvr-2-5/
LOCATION:Fox Cabaret\, 2321 Main Street\, Vancouver
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/fx1_lrg-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260410T225502
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:24324-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260410T225502
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:26606-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-2/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260410T225502
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:28221-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-3/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260410T225502
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:31304-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-4/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260410T225502
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:32764-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-5/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260410T225502
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:24128-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260410T225502
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:26598-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-2/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260410T225502
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:28213-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-3/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260410T225502
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:31296-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-4/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260410T225502
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:32756-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-5/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260410T225502
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:24279-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260410T225502
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:26603-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260410T225502
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:28218-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260410T225502
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:31301-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260410T225502
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:32761-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR